Since GPR43 is also implicated in the etiology of IBD1, 2, 3, 4, it would be interesting to investigate whether GM-CSF exerts any beneficial therapeutic effects through modulating GPR43 expression. Here, CSF2 is linked to inflammatory bowel disease 1.